SCHEMBL7067559

SCHEMBL7067559

CC(=CCC(C)N)c1cnc(N)nc1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4422415 0.81 HCAR2 (0.32)
SCHEMBL5878618 0.80 NOS3 (0.40)
SCHEMBL9723648 0.73 HTR2A (0.47)
SCHEMBL5199056 0.72 TBXAS1 (0.51)
SCHEMBL7529716 0.72 KDM4E (0.40)
SCHEMBL7071014 0.71 TAAR1 (0.34)
SCHEMBL6453865 0.71 KDM4E (0.44)
SCHEMBL8004815 0.70 F2 (0.40)
SCHEMBL25972271 0.66 HDAC1 (0.37) HDAC1HDAC6
SCHEMBL19054763 0.66 HDAC1 (0.34) HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317267-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE Targacept, Inc. (US) 2003-06-11 EP disclosed
EP-1311265-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS Targacept, Inc. (US) 2003-05-21 EP disclosed
WO-2002005801-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2002005798-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS TARGACEPT, INC. (US) 2002-01-24 WO disclosed